Obesity & OverweightNCT07463144
Evaluation of a Mobile Wellness Application and Wearable Fitness Tracker on Weight Management and Health Outcomes
A study testing App + Fitness Tracker and App Only in people with Obesity & Overweight, run by BetterMe Limited at 1 site in United States.
Trial summary
This randomized controlled trial aims to evaluate the effectiveness of a mobile wellness application, both alone and in combination with a wearable fitness tracker, for supporting weight management, physical activity, and mental well-being. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Obesity & Overweight
- What is being tested?
- App + Fitness Tracker and App Only
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 300 participants
- Where
- 1 siteUnited States
- Study dates
- Mar 2026to Aug 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age: 18+ years
- A baseline BMI ≥ 25
- Willing to use the BetterMe mobile wellness app and fitness tracker for the entirety of the study
- Ownership of a smartphone
- Currently inactive, as defined by acknowledging "several times a month" or "never" to the exercise frequency question in the screener
- Acknowledging "I believe I can do it" or "I'm uncertain, but willing to try" to the confidence to succeed question in the screener
- Willingness to use scales for body weighing and submit video recording
Who cannot join
- A baseline BMI < 25
- Pregnant or planning to become pregnant
- Breast-feeding or less than 6 months postpartum
- Currently diagnosed with insomnia, sleep apnea, or other clinical sleep disorder
- Diagnosed thyroid, liver, kidney, cardiovascular, moderate-severe depression or anxiety, bipolar disorder, schizophrenia, or cancer-related disease
- Recent significant weight loss (e.g., >5-10% in the last 6 months)
Show all 11Show fewer
- Extreme life circumstances (e.g. family illness, recently lost job, going through a divorce)
- Cannot participate in a regular exercise routine for any reason during the course of the study (i.e. contraindications to exercise)
- Used the same mobile wellness app and/or fitness tracker in the last year
- Currently enrolled in an additional weight loss program (e.g. Noom, WW, health coaching) and/or working with a dietician
- Current, previous (in the last 6 months), or planned use of weight loss medications (e.g., Ozempic, Wegovy, etc.) (in the next 6 months)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Sterling Institutional Review Board - Remote/Virtual Participation Only
Atlanta, Georgia, 30328
About this study
Official title: Evaluation of App-only Users Compared With Wearable Band + App Users With Regard to Weight Management and Program Engagement on the BetterMe Platform
This randomized controlled trial aims to evaluate the effectiveness of a mobile wellness application, both alone and in combination with a wearable fitness tracker, for supporting weight management, physical activity, and mental well-being. Adults with a body mass index (BMI) ≥25 will be randomized to one of three groups: (1) mobile wellness application + wearable tracker, (2) mobile wellness application only, or (3) control receiving standard health information. Participants will use the interventions over a 12-week period, and outcomes including weight change, activity levels, and self-reported mental health will be assessed.
Read the detailed description
Obesity is a growing public health concern worldwide, contributing to chronic conditions such as type 2 diabetes, cardiovascular disease, and mental health challenges. Digital wellness interventions, including mobile apps and wearable devices, have the potential to support behavior change, physical activity, and weight management.
This study will examine whether adding a wearable fitness tracker to a mobile wellness application enhances health outcomes compared with app-only use or standard health information. The trial is decentralized, conducted remotely, and does not require in-person visits.
Participants will complete baseline assessments, be randomized into one of three study arms, and follow a structured program for 12 weeks. Self-reported surveys, weight measurements (with optional video verification), app usage data, and wearable-collected data (for the tracker group) will be used to evaluate outcomes.
- Conditions
- Obesity & Overweight
- Being tested
- App + Fitness Tracker, App Only, Control Group
- Medical subject headings
- Obesity, Overweight
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
App + Fitness TrackerBehavioural
Participants will use a commercially available mobile wellness app alongside a wearable fitness tracker. The app provides personalized exercise programs, habit tracking, progress monitoring, and motivational support. The wearable collects daily steps, heart rate, heart rate variability, and sleep metrics to enhance personalized feedback. Participants are encouraged to engage with both tools daily over a 12-week period to support weight management, physical activity, and overall well-being.
App OnlyBehavioural
Participants will use the same mobile wellness app without the wearable fitness tracker. The app delivers personalized exercise programs, habit tracking, progress monitoring, and motivational support. Participants are encouraged to use the app daily over 12 weeks to support weight management, physical activity, and overall well-being.
Control GroupBehavioural
Participants will continue their usual health and exercise routines without access to the app or wearable tracker. They will receive standard wellness information via email or blog posts over the 12-week study period. This group serves as a comparison to evaluate the effects of the interventions on weight management, physical activity, and well-being.
| Study group | Role | What they receive |
|---|---|---|
| App + Fitness Tracker | Experimental | Participants using both a mobile wellness app and a wearable fitness tracker. Receives: Behavioral: App + Fitness Tracker |
| App Only | Experimental | participants using only the mobile wellness app. Receives: Behavioral: App Only |
| Control Group | Active comparator | Participants who follow their normal health/ exercise routines, and will receive access to the BetterMe wellness blog and weekly email content to provide general wellness information. Receives: Behavioral: Control Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Weight Change
Change in % body weight
Measured: 3 months
Secondary outcomes (7)
Physical Activity
Physical activity levels (self-reported via IPAQ (International Physical Activity Questionnaire) and wearable devices.
Scale: IPAQ score ranges from 0 to 1000+ MET-minutes/week (where higher scores indicate higher activity levels).
Wearable Tracking: Data from wearable devices will be summarized in minutes of activity per week.
Measured: 3 months
Mental Health: Total Anxiety Score
Measured by the Generalized Anxiety Disorder 7-item scale (GAD-7). The GAD-7 is a 7-item self-report questionnaire used to assess the severity of generalized anxiety disorder. Each item is scored from 0 (not at all) to 3 (nearly every day). The total score is calculated by summing the scores of all 7 items, resulting in a single value ranging from 0 to 21. Higher scores indicate greater anxiety severity.
Measured: 3 months
Mental Health: Depression Total Score
Measured using the Patient Health Questionnaire-8 (PHQ-8). The PHQ-8 is an 8-item self-report instrument used to measure the severity of depressive symptoms. Each item is scored on a 4-point scale ranging from 0 (not at all) to 3 (nearly every day). The total score is calculated by summing the scores of all 8 items, resulting in a single value ranging from 0 to 24. Higher scores indicate greater severity of depressive symptoms.
Measured: 3 months
Health-Related Quality of Life
Short Form 12 (SF-12), Health-Related Quality of Life Scale
Scale: Scores range from 0 to 100 (where higher scores indicate better health-related quality of life).
Measured: 3 months
App usage metrics: Time
Metric: Time spent in app (minutes)
Measured: 3 months
App usage metrics: Exercise Count
Metric: Exercises started/completed (count)
Measured: 3 months
App usage metrics: Frequency
Metric: Frequency of logging (number of logins).
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Mar 2026
- Study startMar 2026 (estimated)
- Primary completionJun 2026 (estimated)
- Study completionAug 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Obesity & OverweightStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 300 participants (estimated)
Sponsor and investigators
- Lead sponsor
- BetterMe Limited
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07463144
- Sponsor's protocol ID
- 12192
- Status last verified
- Mar 2026
- First submitted
- 12 Jan 2026
- Last updated
- 11 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared because the consent obtained from participants does not include permission for sharing de-identified data beyond the study team, and maintaining confidentiality is a priority.
Study at a glance
From the registry record, last updated by the sponsor on 11 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluation of App-only Users Compared With Wearable Band + App Users With Regard to Weight Management and Program Engagement on the BetterMe Platform
- ClinicalTrials.gov ID
- NCT07463144
- Acronym / sponsor ID
- 12192
- Conditions
- Obesity & Overweight
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 300 participants (estimated)
- Lead sponsor
- BetterMe LimitedIndustry (pharma, biotech, devices)
- Study start
- Mar 2026 (estimated)
- Primary completion
- Jun 2026 (estimated)
- Study completion
- Aug 2026 (estimated)
- First posted
- 11 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial aims to evaluate the effectiveness of a mobile wellness application, both alone and in combination with a wearable fitness tracker, for supporting weight management, physical activity, and mental well-being. Adults with a body mass index (BMI) ≥25 will be randomized to one of three groups: (1) mobile wellness application + wearable tracker, (2) mobile wellness application only, or (3) control receiving standard health information. Participants will use the interventions over a 12-week period, and outcomes including weight change, activity levels, and self-reported mental health will be assessed.
Detailed description
Obesity is a growing public health concern worldwide, contributing to chronic conditions such as type 2 diabetes, cardiovascular disease, and mental health challenges. Digital wellness interventions, including mobile apps and wearable devices, have the potential to support behavior change, physical activity, and weight management.
This study will examine whether adding a wearable fitness tracker to a mobile wellness application enhances health outcomes compared with app-only use or standard health information. The trial is decentralized, conducted remotely, and does not require in-person visits.
Participants will complete baseline assessments, be randomized into one of three study arms, and follow a structured program for 12 weeks. Self-reported surveys, weight measurements (with optional video verification), app usage data, and wearable-collected data (for the tracker group) will be used to evaluate outcomes.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| App + Fitness Tracker | Experimental | Behavioral: App + Fitness TrackerParticipants using both a mobile wellness app and a wearable fitness tracker. |
| App Only | Experimental | Behavioral: App Onlyparticipants using only the mobile wellness app. |
| Control Group | Active comparator | Behavioral: Control GroupParticipants who follow their normal health/ exercise routines, and will receive access to the BetterMe wellness blog and weekly email content to provide general wellness information. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Age: 18+ years
- A baseline BMI ≥ 25
- Willing to use the BetterMe mobile wellness app and fitness tracker for the entirety of the study
- Ownership of a smartphone
- Currently inactive, as defined by acknowledging "several times a month" or "never" to the exercise frequency question in the screener
Key exclusion criteria (11 listed)
- A baseline BMI < 25
- Pregnant or planning to become pregnant
- Breast-feeding or less than 6 months postpartum
- Currently diagnosed with insomnia, sleep apnea, or other clinical sleep disorder
- Diagnosed thyroid, liver, kidney, cardiovascular, moderate-severe depression or anxiety, bipolar disorder, schizophrenia, or cancer-related disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| App + Fitness TrackerParticipants will use a commercially available mobile wellness app alongside a wearable fitness tracker. The app provides personalized exercise programs, habit tracking, progress monitoring, and motivational support. The wearable collects daily steps, heart rate, heart rate variability, and sleep metrics to enhance personalized feedback. Participants are encouraged to engage with both tools daily over a 12-week period to support weight management, physical activity, and overall well-being. | Behavioural | App + Fitness Tracker |
| App OnlyParticipants will use the same mobile wellness app without the wearable fitness tracker. The app delivers personalized exercise programs, habit tracking, progress monitoring, and motivational support. Participants are encouraged to use the app daily over 12 weeks to support weight management, physical activity, and overall well-being. | Behavioural | App Only |
| Control GroupParticipants will continue their usual health and exercise routines without access to the app or wearable tracker. They will receive standard wellness information via email or blog posts over the 12-week study period. This group serves as a comparison to evaluate the effects of the interventions on weight management, physical activity, and well-being. | Behavioural | Control Group |
Primary outcome
Weight Change
Time frame: 3 months
Change in % body weight
7 secondary outcomes
Physical Activity
Time frame: 3 months
Mental Health: Total Anxiety Score
Time frame: 3 months
Mental Health: Depression Total Score
Time frame: 3 months
Health-Related Quality of Life
Time frame: 3 months
App usage metrics: Time
Time frame: 3 months
App usage metrics: Exercise Count
Time frame: 3 months
App usage metrics: Frequency
Time frame: 3 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Mar 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared because the consent obtained from participants does not include permission for sharing de-identified data beyond the study team, and maintaining confidentiality is a priority.
Related trials for Obesity & Overweight
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing App + Fitness Tracker and App Only in people with Obesity & Overweight, run by BetterMe Limited at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 11 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Weight Change (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2026.